Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
andropatch
sanol medicinali s.r.l. - testosterone - testosterone
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
sustanon
farmed s.r.l. - testosterone - testosterone
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
testomed
mibe pharma italia s.r.l. - testosterone - testosterone
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
testoviron
gmm farma s.r.l. - testosterone - testosterone
Eiropas Savienība -
itāļu -
EMA (European Medicines Agency)
degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
Itālija -
itāļu -
AIFA (Agenzia Italiana del Farmaco)
stecur
genetic s.p.a. - finasteride - finasteride
Eiropas Savienība -
itāļu -
EMA (European Medicines Agency)
firmagon
ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.